A 68-year-old patient with COPD complains of ongoing dyspnoea despite using a short-acting bronchodilator. According to NICE guidance, which combinati...

Question

A 68-year-old patient with COPD complains of ongoing dyspnoea despite using a short-acting bronchodilator. According to NICE guidance, which combination inhaler is the best next step in therapy for someone with asthmatic features?

Accepted Answer

Long-acting β₂-agonist plus inhaled corticosteroid

Answer

Short-acting β₂-agonist plus ipratropium

Answer

Oral theophylline plus short-acting β₂-agonist

Answer

Long-acting antimuscarinic (LAMA) alone

Answer

Oral corticosteroids

ukmla MCQ (SBA): COPD

A 68-year-old patient with COPD complains of ongoing dyspnoea despite using a short-acting bronchodilator. According to NICE guidance, which combination inhaler is the best next step in therapy for someone with asthmatic features?